89 related articles for article (PubMed ID: 2798447)
1. Influence of inhibitors of the eicosanoid metabolism, and of eicosanoids- and PAF-acether antagonists on mortality and some biochemical parameters of three shock models.
Bahr T; Schaper U; Becker K; Lueddeckens G; Förster W; Scheuch DW; Grupe R
Prog Clin Biol Res; 1989; 301():229-33. PubMed ID: 2798447
[No Abstract] [Full Text] [Related]
2. PAF-induced death in NMRI mice--a suitable shock model for testing new PAF receptor antagonists. Correlation with eicosanoid related substances.
Becker K; Lueddeckens G; Grupe R; Förster W
Prostaglandins Leukot Essent Fatty Acids; 1993 Mar; 48(3):265-71. PubMed ID: 8385779
[TBL] [Abstract][Full Text] [Related]
3. Influence of inhibitors of the eicosanoid metabolism, of antagonists of the eicosanoids and of PAF on mortality assayed in three biochemically characterized shock models.
Bahr T; Schaper U; Becker K; Lueddeckens G; Förster W; Scheuch DW; Grupe R; Göres E
Biomed Biochim Acta; 1988; 47(10-11):S289-92. PubMed ID: 3150272
[TBL] [Abstract][Full Text] [Related]
4. Influence of the specific antagonist of PAF-acether, BN 52021, on the rejection of murine tail skin allografts and the PAF-acether mortality in mice in particular consideration of the role of TXB2.
Becker K; Lueddeckens G; Braquet P; Förster W
Prog Clin Biol Res; 1989; 301():499-503. PubMed ID: 2798460
[No Abstract] [Full Text] [Related]
5. Endotoxin shock, kinin system and PAF-acether in the rat.
Damas J; Remacle-Volon G; Adam A; Bourdon V
Adv Exp Med Biol; 1989; 247B():547-52. PubMed ID: 2610092
[No Abstract] [Full Text] [Related]
6. Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia.
Fletcher JR; DiSimone AG; Earnest MA
Ann Surg; 1990 Mar; 211(3):312-6. PubMed ID: 2178565
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of rat endotoxin-induced lethality by BN 52021 and BN 52063, compounds with PAF-acether antagonistic effect and protease-inhibitory activity.
Etienne A; Hecquet F; Guilmard C; Soulard C; Braquet P
Int J Tissue React; 1987; 9(1):19-26. PubMed ID: 3596954
[TBL] [Abstract][Full Text] [Related]
8. The involvement of platelet-activating factor (PAF)-induced monocyte activation and tumor necrosis factor (TNF) production in shock.
Bonavida B; Paubert-Braquet M; Hosford D; Braquet P
Prog Clin Biol Res; 1989; 308():485-9. PubMed ID: 2780710
[No Abstract] [Full Text] [Related]
9. Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L.
Braquet P
Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():179-98. PubMed ID: 2949548
[No Abstract] [Full Text] [Related]
10. Effect of PAF-antagonists in endotoxin shock--ovine and rat experiments.
Bahrami S; Redl H; Thurnher M; Vogl C; Paul E; Schiesser A; Schlag G
Prog Clin Biol Res; 1989; 308():931-6. PubMed ID: 2780740
[No Abstract] [Full Text] [Related]
11. PAF-induced amplification of mediator release in septic shock: prevention or downregulation by PAF antagonists.
Koltai M; Hosford D; Braquet P
J Lipid Mediat; 1993; 6(1-3):183-98. PubMed ID: 8357981
[No Abstract] [Full Text] [Related]
12. Release of eicosanoids in rat peritoneal cavity stimulated with platelet-activating factor (PAF). Effect of the PAF-antagonist BN-52021.
Jancar S; Braquet P; Sirois P
Prostaglandins Leukot Essent Fatty Acids; 1989 Jul; 37(1):23-4. PubMed ID: 2548218
[TBL] [Abstract][Full Text] [Related]
13. Chemotactic effect of PAF-acether on peritoneal eosinophils from normal rats.
Martins MA; Etienne A; Soulard C; Domingo MT; Braquet P
Braz J Med Biol Res; 1989; 22(9):1151-4. PubMed ID: 2636011
[TBL] [Abstract][Full Text] [Related]
14. In vivo inhibition of plasma protein leakage and Salmonella enteritidis-induced mortality in the rat by a specific paf-acether antagonist: BN 52021.
Etienne A; Hecquet F; Soulard C; Spinnewyn B; Clostre F; Braquet P
Agents Actions; 1986 Jan; 17(3-4):368-70. PubMed ID: 3515870
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological control of the in vivo passive anaphylactic shock by the PAF-acether antagonist compound BN 52021.
Vilain B; Lagente V; Touvay C; Desquand S; Randon J; Lefort J; Braquet P; Vargaftig BB
Pharmacol Res Commun; 1986 Aug; 18 Suppl():119-26. PubMed ID: 3774840
[TBL] [Abstract][Full Text] [Related]
16. Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats.
López-Farré A; Bernabeu F; Gómez-Garre D; Ramon y Cajal S; Braquet P; López-Novoa JM
J Pharmacol Exp Ther; 1990 Apr; 253(1):328-33. PubMed ID: 2329516
[TBL] [Abstract][Full Text] [Related]
17. Influence of platelet activating factor antagonists on the protamine sulphate stimulated release of histamine from peritoneal mast cells of rats in vitro.
Lohde C; Bahr T; Labes D; Grupe R
Arzneimittelforschung; 1992 Jan; 42(1):27-31. PubMed ID: 1375025
[TBL] [Abstract][Full Text] [Related]
18. Myoelectric intestinal disturbances in Escherichia coli endotoxic shock in rats. Involvement of platelet-activating factor.
Pons L; Droy-Lefaix MT; Braquet P; Buéno L
Lipids; 1991 Dec; 26(12):1359-61. PubMed ID: 1819734
[TBL] [Abstract][Full Text] [Related]
19. Influence of aminophylline and ketotifen in comparison to the lipoxygenase inhibitors NDGA and esculetin and the PAF antagonists WEB 2170 [correction of 2107] and BN 52021 on endothelin-1 induced vaso- and bronchoconstriction.
Lueddeckens G; Becker K; Rappold R; Förster W
Prostaglandins Leukot Essent Fatty Acids; 1991 Nov; 44(3):155-8. PubMed ID: 1808625
[TBL] [Abstract][Full Text] [Related]
20. PAF-acether and endotoxin display similar effects on rat mesenteric microvessels: inhibition by specific antagonists.
Lagente V; Fortes ZB; Garcia-Leme J; Vargaftig BB
J Pharmacol Exp Ther; 1988 Oct; 247(1):254-61. PubMed ID: 3171975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
